Emergent BioSolutions EBS
NYSE EBS
$6.22 +0.02 (+0.32%)
As of: Oct 22, 2026 · 3:59 PM EDT

Emergent BioSolutions (EBS) Price to Earnings (2011 - 2025)

Updated

Emergent BioSolutions' (EBS) Price to Earnings came in at 12.24 for Q4 2025, up 99.9% from the prior quarter.

Analysis

Emergent BioSolutions (EBS) Price to Earnings (2011 - 2025) Analysis & Trends

Since Q4 2011, Emergent BioSolutions has reported Price to Earnings for 46 quarters.

  • In prior years, Emergent BioSolutions' Price to Earnings was 10.16 in FY2021 (-34.7%).
  • The Q4 2025 figure stands as the highest quarterly Price to Earnings since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Emergent BioSolutions 319.92 Mn -430.98 Mn 137.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 12.24
Sep 30, 2025 6.12
Jun 30, 2025 2.46
Sep 30, 2022 21.60
Jun 30, 2022 16.27
Mar 31, 2022 14.02
Dec 31, 2021 10.16
Sep 30, 2021 12.69
Jun 30, 2021 11.60
Mar 31, 2021 12.94
Dec 31, 2020 15.59
Sep 30, 2020 32.87
Jun 30, 2020 24.56
Mar 31, 2020 44.44
Dec 31, 2019 51.18
Sep 30, 2019 642.30
Mar 31, 2019 62.57
Dec 31, 2018 48.41
Sep 30, 2018 33.02
Jun 30, 2018 22.41
API Access

Emergent BioSolutions Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=EBS&period=max&api_key=YOUR_API_KEY